ClinicalTrials.Veeva

Menu

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

C

Chongqing University Cancer Hospital

Status

Completed

Conditions

Epithelial Ovarian Cancer
Adnexal Mass

Study type

Observational

Funder types

Other

Identifiers

NCT06366997
CQGOG0207

Details and patient eligibility

About

The study is designed to confirm the performance of the 3D Medicines Corporation OCS test in diagnosis of epithelial ovarian cancer in patients with adnexal mass. To this end, blood samples from female patients with adnexal mass required surgical resection from four centers are obtained and analysis in the study.

Enrollment

1,352 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • a) ≥ 18 years of age;
  • b) Patients with adnexal masses;
  • c) Sign the informed consent form;
  • d) Adnexal mass that requires excision;

Exclusion criteria

  • a) history of chemoradiotherapy;
  • b) history of malignancy;
  • c) pregnancy;
  • d) Adnexal mass not require surgical excision;
  • e) The adnexal mass has been diagnosed as malignant before surgery, and the number of cases enrolled in a single institution exceeds 50;
  • f) Blood CA125 value greater than 1000 U/ml at initial treatment.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems